![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CLINICAL CASES
Giornale Italiano di Dermatologia e Venereologia 2002 April;137(2):151-3
Copyright © 2002 EDIZIONI MINERVA MEDICA
language: Italian
Cutaneous drug eruption induced by oxcarbamazepine. Case report
Gisondi P., Romano I., Sasso E., Guadagni M., Alinovi A.
Università degli Studi - Parma Facoltà di Medicina e Chirurgia Istituto di Dermatologia Medica e Chirurgica *Istituto di Clinica Neurologica
Oxcarbazepine (OCBZ), a 10-keto derivative of carbamazepine (CBZ) has been reported to have a similar range of efficacy and fewer side effects than CBZ because its biotrasformation in humans is quite different. Because of its pharmacokinetic advantages and efficay, OCBZ is considered the drug of first choice for epileptic disorders in which CBZ is currently indicated. Allergic skin reactions are rare with OCBZ and cross reactivity is seen only in about a fourth of patients hypersensitive to CBZ. A case of skin drug eruption induced by OCBZ is reported.